Articles published by Altamira Therapeutics Ltd
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
April 10, 2024
Via GlobeNewswire
Tickers
CYTO
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
December 29, 2023
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Provides Investor and Business Update
December 11, 2023
Via GlobeNewswire
Tickers
CYTO
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
November 29, 2023
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
November 17, 2023
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
September 12, 2023
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
September 06, 2023
Via GlobeNewswire
Tickers
CYTO
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Provides Year-End 2022 Business Update
December 19, 2022
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Provides Business Update and First Half 2022 Financial Results
November 30, 2022
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Announces Launch of Bentrio in Hong Kong by its Partner Nuance Pharma
November 30, 2022
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics to Participate at TIDES Europe Oligonucleotide and Peptide Therapeutics Hybrid Event
November 10, 2022
Via GlobeNewswire
Tickers
CYTO
Altamira Therapeutics Regains Listing Compliance with NASDAQ Minimum Bid Requirement
November 09, 2022
Via GlobeNewswire
Tickers
CYTO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.